Suboxone is a Buccal; Sublingual Film, Soluble in the Human Prescription Drug category. It is labeled and distributed by Indivior Inc.. The primary component is Buprenorphine Hydrochloride; Naloxone Hydrochloride.
| Product ID | 12496-1202_1e2afa2f-2bc7-481c-a1f6-97632642199f |
| NDC | 12496-1202 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Suboxone |
| Generic Name | Buprenorphine Hydrochloride, Naloxone Hydrochloride |
| Dosage Form | Film, Soluble |
| Route of Administration | BUCCAL; SUBLINGUAL |
| Marketing Start Date | 2010-09-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA022410 |
| Labeler Name | Indivior Inc. |
| Substance Name | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
| Active Ingredient Strength | 2 mg/1; mg/1 |
| Pharm Classes | Opioid Antagonist [EPC], Opioid Antagonists [MoA], Partial Opioid Agonist [EPC], Partial Opioid Agonists [MoA] |
| DEA Schedule | CIII |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2010-09-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA022410 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-09-13 |
| Marketing Category | NDA |
| Application Number | NDA022410 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2010-09-13 |
| Ingredient | Strength |
|---|---|
| BUPRENORPHINE HYDROCHLORIDE | 2 mg/1 |
| SPL SET ID: | 8a5edcf9-828c-4f97-b671-268ab13a8ecd |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 12496-1202 | Suboxone | buprenorphine hydrochloride, naloxone hydrochloride |
| 12496-1204 | Suboxone | buprenorphine hydrochloride, naloxone hydrochloride |
| 12496-1212 | Suboxone | Suboxone |
| 12496-1208 | Suboxone | Suboxone |
| 53217-328 | Suboxone | Suboxone |
| 55700-147 | Suboxone | Suboxone |
| 63629-4028 | Suboxone | Suboxone |
| 0781-7216 | BUPRENORPHINE AND NALOXONE | buprenorphine hydrochloride, naloxone hydrochloride |
| 0781-7227 | BUPRENORPHINE AND NALOXONE | buprenorphine hydrochloride, naloxone hydrochloride |
| 0781-7238 | BUPRENORPHINE AND NALOXONE | buprenorphine hydrochloride, naloxone hydrochloride |
| 0781-7249 | BUPRENORPHINE AND NALOXONE | buprenorphine hydrochloride, naloxone hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SUBOXONE 78303449 2917297 Dead/Cancelled |
Reckitt Benckiser Healthcare (UK) Limited 2003-09-22 |
![]() SUBOXONE 77727995 3917631 Live/Registered |
INDIVIOR UK LIMITED 2009-05-04 |
![]() SUBOXONE 75226449 2169133 Live/Registered |
INDIVIOR UK LIMITED 1997-01-16 |